Recurrence and outcomes of non‐functional pancreatic neuroendocrine tumours post‐resection: an Australian retrospective, multicentre cohort study
暂无分享,去创建一个
Sean-Tee J. M. Lim | D. Croagh | S. Banting | L. Chong | Saania Peeroo | Olukunle Onasanya | Evelyn He
[1] T. Pawlik,et al. Identifying Risk Factors and Patterns for Early Recurrence of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study , 2021, Cancers.
[2] Fei Li,et al. Head and body/tail pancreatic neuroendocrine tumors have different biological characteristics and clinical outcomes , 2020, Journal of Cancer Research and Clinical Oncology.
[3] Xubao Liu,et al. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors , 2020, Medicine.
[4] T. Pawlik,et al. Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence. , 2020, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[5] Jin‐Young Jang,et al. Validation of the 8th AJCC Cancer Staging System for Pancreas Neuroendocrine Tumors Using Korean Nationwide Surgery Database , 2019, Cancer research and treatment : official journal of Korean Cancer Association.
[6] K. Chouliaras,et al. Analysis of recurrence after the resection of pancreatic neuroendocrine tumors , 2018, Journal of surgical oncology.
[7] A. Scarpa,et al. Patterns of Recurrence after Resection for Pancreatic Neuroendocrine Tumors: Who, When, and Where? , 2018, Neuroendocrinology.
[8] Shouhao Zhou,et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States , 2017, JAMA oncology.
[9] D. Gouma,et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After , 2017, Surgery.
[10] Xiao‐Yu Yin,et al. Surgery management for sporadic small (≤2 cm), non-functioning pancreatic neuroendocrine tumors: a consensus statement by the Chinese Study Group for Neuroendocrine Tumors (CSNET). , 2017, International journal of oncology.
[11] Michael M Maher,et al. Computed tomography and patient risk: Facts, perceptions and uncertainties , 2016, World journal of radiology.
[12] H. S. King,et al. Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries , 2016, British journal of anaesthesia.
[13] R. Jensen,et al. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors , 2016, Neuroendocrinology.
[14] R. Yu,et al. Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment , 2013, Chinese journal of cancer.
[15] M. Koch,et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. , 2011, Surgery.
[16] Abe Fingerhut,et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. , 2007, Surgery.
[17] N. Demartines,et al. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.
[18] OUP accepted manuscript , 2022, The Oncologist.